Clinical Trial Update: Optical Tissue Identification for Myocardial Architecture [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on optical tissue identification for myocardial architecture in congenital heart defect conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complete Atrioventricular Canal Defect
• Tetralogy of Fallot with Pulmonary Stenosis
• Ventricular Septal Defect

Snippet

Sponsor: Aditya Kaza | Conditions: Ventricular Septal Defect, Complete Atrioventricular Canal | Phase 2 | Status: ACTIVE_NOT_RECRUITING